TMC207: Promising new drug for tuberculosis

Submitted by Bobby Ramakant (bobby) about 3 days ago

You like?

3

Or not?

Photo by prudencebrown121 Addition of the new drug, TMC207 to standard multidrug-resistant TB (MDR-TB) treatment regimens dramatically cuts the period from when patients start treatment to their sputum testing negative for TB. This new drug, TMC207 is being developed by a pharmaceutical research company, Tibotec, in collaboration with TB Alliance. Read more...

Addition of the new drug, TMC207 to standard multidrug-resistant TB (MDR-TB) treatment regimens dramatically cuts the period from when patients start treatment to their sputum testing negative for TB. This new drug, TMC207 is being developed by a pharmaceutical research company, Tibotec, in collaboration with TB Alliance.

Keywords: drug resistance extensively drug-resistant M/XDR-TB MDR-TB multi-drug resistant research TB TMC207 tuberculosis XDR-TB

Translate to:

Some parts of London have TB incidence as high as high-burden TB countries

Submitted by Bobby Ramakant (bobby) about 3 days ago

You like?

3

Or not?

Photo by Axel Rouvin TB anywhere is TB everywhere! In some parts of London, TB incidence is as high as in most high-burden TB countries like India. Read more...

TB anywhere is TB everywhere! In some parts of London, TB incidence is as high as in most high-burden TB countries like India.

Keywords: drug resistance extensively drug-resistant M/XDR-TB MDR-TB multi-drug resistant TB tuberculosis XDR-TB

Translate to:

Stop-TB eCorrespondent: 22-30 June 2009

Submitted by Bobby Ramakant (bobby) about 3 days ago

You like?

2

Or not?

Photo by bobbyramakant The Stop-TB eCorrespondent provides a weekly snapshot of five major news on TB control from around the world, TB and HIV news highlights from TB high-burdened countries in the past week and links to major events on TB and HIV in the coming week. This is Issue 45 (22-30 June 2009).
Top five TB/HIV headlines in the past week:
1. Soaring global health funds not all wisely spent: studies
2. US$ 196 billion: Little proof UN health programmes work
3. Promising new drug for tuberculosis
4. Some parts of London have TB incidence as high as high-burden TB countries
5. Participate in forging new tools for improving TB and HIV care Read more...

The Stop-TB eCorrespondent provides a weekly snapshot of five major news on TB control from around the world, TB and HIV news highlights from TB high-burdened countries in the past week and links to major events on TB and HIV in the coming week. This is Issue 45 (22-30 June 2009).Top five TB/HIV headlines in the past week:1. Soaring global health funds not all wisely spent: studies2. US$ 196 billion: Little proof UN health programmes work3. Promising new drug for tuberculosis4. Some parts of London have TB incidence as high as high-burden TB countries5. Participate in forging new tools for improving TB and HIV care

Keywords: drug resistance drugs extensively drug-resistant M/XDR-TB MDR-TB multi drug-resistant Stop-TB eCorrespondent TB TB TB/HIV tuberculosis XDR-TB

Translate to:

$196 billion; little proof UN health programs work

Submitted by Bobby Ramakant (bobby) about 3 days ago

You like?

2

Or not?

Photo by psyberartist In the last two decades, the world has spent more than $196 billion trying to save people from death and disease in poor countries. However it's tough to gauge the effectiveness of pricey programs led by the United Nations and its partners, and in some cases, big spending may even be counterproductive. The study also concluded some UN programs hurt health care in Africa by disrupting basic services and leading some countries to slash their health spending. Read more...

In the last two decades, the world has spent more than $196 billion trying to save people from death and disease in poor countries. However it's tough to gauge the effectiveness of pricey programs led by the United Nations and its partners, and in some cases, big spending may even be counterproductive. The study also concluded some UN programs hurt health care in Africa by disrupting basic services and leading some countries to slash their health spending.

Keywords: drug resistance Health Financing health funding health systems TB tuberculosis UN

Translate to:

Going after chronic coughers to identify tuberculosis cases in Uganda

Submitted by Bobby Ramakant (bobby) about 3 days ago

You like?

4

Or not?

Photo by srqpix Identifying individuals with chronic cough lasting over two weeks to test them for tuberculosis (Active Case Finding) could supplement the current strategy where suspects voluntarily avail themselves to health facilities (Passive Case Finding) for diagnosis, according to a study. Read more...

Identifying individuals with chronic cough lasting over two weeks to test them for tuberculosis (Active Case Finding) could supplement the current strategy where suspects voluntarily avail themselves to health facilities (Passive Case Finding) for diagnosis, according to a study.

Keywords: case finding chronic contact tracing cough drug resistance extensively drug-resistant M/XDR-TB MDR-TB multi-drug resistant TB tuberculosis XDR-TB

Translate to:

HIV prevention by Female Condom (FC)

Submitted by Kintu about 1 day ago

You like?

3

Or not?

The only HIV prevention measure controlled by women is the female condom. Uganda's Ministry of Health is planning to roll-out a massive campaign to reintroduce the prevention practice, but many challenges stand in the way of a successful programme. Read more...

The only HIV prevention measure controlled by women is the female condom. Uganda's Ministry of Health is planning to roll-out a massive campaign to reintroduce the prevention practice, but many challenges stand in the way of a successful programme.

Keywords: advocacy condom female health HIV policy prevention programme STI women

Translate to:

Treatment should be a center of focus to save the hundreds of people with HIV/AIDS

Submitted by sanyu about 2 days ago

You like?

5

Or not?

Treatment for people living with HIV is still very low in Uganda. Unlike other countries where people living with HIV/AIDS have quick treatment, in Uganda it is a nightmare. More than 400,000 people are in dire need of treatment, but less than 170,000 can access it. Read more...

Treatment for people living with HIV is still very low in Uganda. Unlike other countries where people living with HIV/AIDS have quick treatment, in Uganda it is a nightmare. More than 400,000 people are in dire need of treatment, but less than 170,000 can access it.

Keywords: Access AIDS gaps HIV lobby status treatment

Translate to:

Choose your group

Support

Featured KC

Group members

This is HealthDev.net

TMC207: Promising new drug for tuberculosis

Some parts of London have TB incidence as high as high-burden TB countries

Stop-TB eCorrespondent: 22-30 June 2009

$196 billion; little proof UN health programs work

Going after chronic coughers to identify tuberculosis cases in Uganda

HIV prevention by Female Condom (FC)

Treatment should be a center of focus to save the hundreds of people with HIV/AIDS

Toolbox

Subscribe to email updates

Search